Should Biotech Be On The Critical List? By: TalkMarkets May 11, 2022 at 01:10 AM EDT The risk-off market has played havoc with the biotechs where the fundamentals have not changed as much as the valuation. Read More >> Related Stocks: Alaunos Therapeutics, Inc. - Common Stock Biontech Se ADR Enlivex Therapeutics Ltd Nasdaq Biotechnology Ishares ETF S&P Biotech SPDR
